Patents Assigned to Igene Biotechnology, Inc.
-
Publication number: 20120253078Abstract: A food supplement for finishing hogs containing astaxanthin is described.Type: ApplicationFiled: June 17, 2012Publication date: October 4, 2012Applicant: IGENE BIOTECHNOLOGY, INC.Inventors: Patrick Monahan, Stephen Hiu
-
Publication number: 20110130464Abstract: A composition of ractopamine and astaxanthin, included as additives in a feed, for finishing hogs, improves carcass performance.Type: ApplicationFiled: July 20, 2009Publication date: June 2, 2011Applicant: IGENE BIOTECHNOLOGY, INC.Inventors: Patrick Monahan, Stephen Hiu
-
Publication number: 20100240766Abstract: A food supplement for finishing hogs containing astaxanthin is described.Type: ApplicationFiled: November 6, 2008Publication date: September 23, 2010Applicant: IGENE BIOTECHNOLOGY, INC.Inventors: Patrick Monahan, Stephen Hiu
-
Patent number: 7723066Abstract: An economical process for in vivo production of the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating surviving pigment enhanced microorganisms, and harvesting the yeast.Type: GrantFiled: June 1, 1995Date of Patent: May 25, 2010Assignee: Igene Biotechnology, Inc.Inventors: Eric A. Johnson, Huei-hsiung Yang, Beril Geldiay-Tuncer, William T. Hall, David Schreiber, Kwok Ho
-
Patent number: 5356809Abstract: An economical process for in vivo production of the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating surviving pigment enhanced microorganisms, and harvesting the yeast.Type: GrantFiled: February 14, 1992Date of Patent: October 18, 1994Assignee: Igene Biotechnology, Inc.Inventors: Eric A. Johnson, Huei-hsiung Yang, Beril Geldiay-Tuncer, William T. Hall, David Schreiber, Kwok Ho
-
Patent number: 5182208Abstract: An economical process for in vivo production of the pigment astaxanthin, and particularly a process for enhancing astaxanthin content of cultures of microorganisms of genus Phaffia, the process comprising culturing a microorganism of genus Phaffia in a nutrient medium containing an antibiotic, a cytochrome B inhibitor, or a terpenoid synthetic pathway inhibitor, cultivating surviving pigment enhanced microorganisms, and harvesting the yeast.Type: GrantFiled: August 23, 1989Date of Patent: January 26, 1993Assignee: Igene Biotechnology, Inc.Inventors: Eric A. Johnson, David Schreiber, Kwok P. Ho, William T. Hall, Huei-hsiung Yang, Beril Geldiay-Tuncer
-
Patent number: 5057141Abstract: Soybean meal and urea compositions have been found to exhibit enhanced and commercially useful nematistatic and nematicidal activity in soils. Chitin-containing materials, e.g., crab shells, shrimp shells, fungal mycella, etc., have also been found to exhibit enhanced and commercially useful nematistatic and nematicidal activity in soils when admixed with other organic nitrogen-containing materials such as ammonium phosphates, a source of urea, and plant, fish or animal meal. Also, compositions formulated of two different chitin source materials can be used. The soybean-urea compositions as well as the blended chitin-containing formulations are non-phytotoxic and simultaneously provide cost-effective biological suppression of plant pathogenic nematode populations and excellent plant nutrition.Type: GrantFiled: August 1, 1988Date of Patent: October 15, 1991Assignee: Igene Biotechnology Inc.Inventors: R. Rodriquez-Kabana, Robert A. Milch
-
Patent number: 4859597Abstract: A method for producing a lysin-free phage inoculum, which comprises:(a) inoculating a growing Streptococcal culture with phage,(b) incubating the culture for a plurality of lytic cycles of phage until the cells are completely lysed to obtain a lysate, and(c) removing cell debris and free lysin from the lysate to form a lysin-free phage suitable for use as an inoculum.A method for producing lysin is also disclosed.Type: GrantFiled: July 27, 1987Date of Patent: August 22, 1989Assignee: Igene Biotechnology, Inc.Inventors: Huei-Hsiung Yang, Stephen F. Hiu, John L. Harris
-
Patent number: 4794080Abstract: A simultaneous sequential anaerobic fermentation process for the in vitro production of propionic and acetic acids is disclosed. The process comprises employing an obligatory two-component co-culture which maintains a relatively constant ratio of species populations over multiple passages. A first co-culture component is a Lactobacillus or Streptococcus which homofermentatively converts the hexose to lactic acid. A second microorganism in the co-culture is a Veillonella which is metabolically incapable of assimillating the hexose and converts the lactic acid product to propionic and acetic acids. The co-culture is inoculated into a nutrient growth feedstock such as whole whey or a clarified dairy whey lactose permeate which contains a metabolizable source of a hexose such as glucose, lactose or sucrose.Type: GrantFiled: April 16, 1984Date of Patent: December 27, 1988Assignee: IGENE Biotechnology, Inc.Inventors: Thomas D. Mays, Pamela N. Fornili
-
Patent number: 4769254Abstract: A water-soluble levan having a weight average molecular weight of about 10,000-40 million, preferably about 5-25 million and especially about 10-20 million which stabilizes a bovine serum albumin colloid having index (EAI) of about 3-100 determined according to the formula EAI=2T/OC wherein T is turbidity measured at 500 nm, C is the weight of emulsified protein per unit volume of the aqueous phase, and O is the volume fraction of a dispersed oil phase is produced by fermenting a nutrient growth medium feedstock having a carbon source consisting essentially of an assimilable sugar selected from the group consisting of sucrose, raffinose, or a mixture thereof with a microorganism capable of converting at least 50%. of the fructose value of the sugar to said levan under nutrient growth conditions which enhance levan production while suppressing ethanol production. It is useful as a colloid stabilizing agent, particularly with foods, beverages, pharmaceuticals, dentifrices, and cosmetics.Type: GrantFiled: September 26, 1985Date of Patent: September 6, 1988Assignee: Igene Biotechnology, Inc.Inventors: Thomas D. Mays, Ellen L. Dally
-
Patent number: 4670251Abstract: A solid pharmaceutical composition suitable for oral or rectal administration comprising a unit dosage of a pharmaceutically active ingredient (and optionally one or more inert fillers) homogeneously dispersed in a pharmaceutically acceptable binder, wherein at least a major portion (i.e., at least 50% by weight) of the binder is a microcrystalline solid phase prepared by raising the pH of a dairy whey lactose permeate having a pH below about 7 to a pH between about 8 and 10 to form (i) a lactose-rich aqueous solute phase capable of being autoclaved for 10-20 minutes at 121.degree. C.Type: GrantFiled: September 20, 1984Date of Patent: June 2, 1987Assignee: Igene Biotechnology, Inc.Inventor: John F. Blanco